Future Therapies

The therapeutic potential for Wharton's Jelly/Cord Tissue stem cells is enormous. The Mesenchymal stem cell (MSC) is fast becoming the cell of choice for tissue engineering and regenerative medicine because of the plasticity and ability to be induced to develop into other cell types. These cell types include: adipose tissue, bone, cartilage, skeletal muscle, cardiomyocyte-like cells and neural cells. Collecting an autologous sample of your child's Wharton's Jelly/Cord Tissue stem cells at birth provides your child with the opportunity to benefit from medical advances in cellular therapy.

Saving your child’s Wharton’s Jelly/Cord Tissue with an Auxocell partner cord blood bank ensures that your child’s stem cells will be processed utilizing the gold standard of Wharton’s Jelly/Cord Tissue stem cell banking. Working with an Auxocell partner cord blood bank will also provide you with the piece of mind and added benefit of knowing that should you need to expand your Wharton’s Jelly/Cord Tissue stem cells that you are able to do so following Auxocell’s patented processing protocols.